Clinical Outcome After Total Knee Arthroplasty Using CR or PS Inlay
NCT ID: NCT03873363
Last Updated: 2024-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
140 participants
INTERVENTIONAL
2018-04-01
2030-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Substitution of the PCL in TKA With UC or PS Design
NCT04679857
Total Knee Arthroplasty: Functional and Clinical Outcomes
NCT01811563
Comparison of Radiological, Clinical, Functional Outcomes Between Anatomically Aligned Total Knee Arthroplasty and Conventional Total Knee Arthroplasty
NCT04183985
Clinical Outcome and Cytokine Expression After TKA
NCT03424174
A Comparison of Anatomically Aligned Versus Conventional in Unilateral Total Knee Arthroplasty
NCT04181528
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For this purpose, flexion and extension of the knee joint are measured using a goniometer preoperatively and up to ten years after surgery In addition, the clinical outcome will be assessed and evaluated using internationally recognised and evaluated scores (Knee Society Score, Oxford Knee Score, EQ5D, UCLA Activity Score).
Patients are randomized to receive a PS or CR TKA. Patients are assessed before surgery, after 3 months, 1 year, 2 years, 5 years, 7 years and 10 years postoperatively.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PS
Implantation of a posterior stabilized (cruciate substituting) Total Knee Arthroplasty.
PS TKA
Implantation of a posterior stabilized (cruciate substituting) Total Knee Arthroplasty.
CR
Implantation of a cruciate retaining Total Knee Arthroplasty.
CR TKA
Implantation of a cruciate retaining Total Knee Arthroplasty.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PS TKA
Implantation of a posterior stabilized (cruciate substituting) Total Knee Arthroplasty.
CR TKA
Implantation of a cruciate retaining Total Knee Arthroplasty.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written informed consent
Exclusion Criteria
* Neuromuscular Diseases
* general illnesses that make mobilisation more difficult and/or prevent follow-up
* Known posterior cruciate ligament insufficiency
* Need for a higher degree of linkage
* BMI over 40 kg/m²
* Study doctor, his family, employees or other dependent persons
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technische Universität Dresden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Center of Orthopaedics and Traumatology, University Medicine Carl Gustav Carus Dresden, TU Dresden
Dresden, Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TKA CR vs PS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.